Recombinant insulin-like growth factor-1 improves cardiac function and symptoms in the patients on the waiting list for heart transplantation with end-stage dilated cardiomyopathy

27 August 2017 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Inflammation, diabetes and their influence on the heart Drug therapy ESC Premium Access ESC Congress 2017

ESC 365 is supported by

ESC 365 is supported by